REFERENCES
- Contreras F, Fouillioux C, Bolivar A, . Endothelium and hypertensive disorders in pregnancy. Am J Ther 2003; 10:415–422.
- Abrams J. Beneficial actions of nitrates in cardiovascular disease. Am J Cardiol 1996; 77:31C–37C.
- Moncada S, Higgs A. The l-arginine-nitric oxide pathway. N Engl J Med 1993; 329:2002–2012.
- Buhimschi I, Yallampalli C, Chwalisz K, Garfield RE. Pre-eclampsia-like conditions produced by nitric oxide inhibition: Effects of l-arginine, d-arginine and steroid hormones. Hum Reprod 1995; 10:2723–2730.
- Altun ZS, Uysal S, Guner G, Yilmaz O, Posaci C. Effects of oral l-arginine supplementation on blood pressure and asymmetric dimethylarginine in stress-induced preeclamptic rats. Cell Biochem Funct 2008; 26:648–653.
- Alexander BT, Llinas MT, Kruckeberg WC, Granger JP. l-arginine attenuates hypertension in pregnant rats with reduced uterine perfusion pressure. Hypertension 2004; 43:832–836.
- Miller AL. The effects of sustained-release-l-arginine formulation on blood pressure and vascular compliance in 29 healthy individuals. Altern Med Rev 2006; 11:23–29.
- Doroszko A, Andrzejak R, Szuba A. Role of the nitric oxide metabolic pathway and prostanoids in the pathogenesis of endothelial dysfunction and essential hypertension in young men. Hypertens Res 2011; 34:79–86.
- Facchinetti F, Saade GR, Neri I, Pizzi C, Longo M, Volpe A. l-arginine supplementation in patients with gestational hypertension: A pilot study. Hypertens Pregnancy 2007; 26:121–130.
- Hladunewich MA, Derby GC, Lafayette RA, Blouch KL, Druzin ML, Myers BD. Effect of l-arginine therapy on the glomerular injury of preeclampsia: A randomized controlled trial. Obstet Gynecol 2006; 107:886–895.
- Neri I, Monari F, Sgarbi L, Berardi A, Masellis G, Facchinetti F. l-arginine supplementation in women with chronic hypertension: Impact on blood pressure and maternal and neonatal complications. J Matern Fetal Neonatal Med 2010; 23:1456–1460.
- Staff AC, Berge L, Haugen G, Lorentzen B, Mikkelsen B, Henriksen T. Dietary supplementation with l-arginine or placebo in women with pre-eclampsia. Acta Obstet Gynecol Scand 2004; 83:103–107.
- Rytlewski K, Olszanecki R, Korbut R, Zdebski Z. Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia. Eur J Clin Invest 2005; 35:32–37.
- Neri I, Jasonni VM, Gori GF, Blasi I, Facchinetti F. Effect of l-arginine on blood pressure in pregnancy-induced hypertension: A randomized placebo-controlled trial. J Matern Fetal Neonatal Med 2006; 19:277–281.
- Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999; 354:1896–1900.
- Moher D, Pham B, Jones A, . Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998; 352:609–613.
- Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557–560.
- DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177–188.
- Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629–634.
- Facchinetti F, Longo M, Piccinini F, Neri I, Volpe A. l-arginine infusion reduces blood pressure in preeclamptic women through nitric oxide release. J Soc Gynecol Investig 1999; 6:202–207.
- Facchinetti F, Neri I, Piccinini F, . Effect of l-arginine load on platelet aggregation: A comparison between normotensive and preeclamptic pregnant women. Acta Obstet Gynecol Scand 1999; 78:515–519.
- Maas R, Boger RH, Schwedhelm E, . Plasma concentrations of asymmetric dimethylarginine (ADMA) in Colombian women with pre-eclampsia. J Am Med Assoc 2004; 291:823–824.
- Neri I, Blasi I, Facchinetti F. Effects of acute l-arginine infusion on non-stress test in hypertensive pregnant women. J Matern Fetal Neonatal Med 2004; 16:23–26.
- Winer N, Branger B, Azria E, . Arginine treatment for severe vascular fetal intrauterine growth restriction: A randomized double-bind controlled trial. Clin Nutr 2009; 28:243–248.
- Modin A, Bjorne H, Herulf M, Alving K, Weitzberg E, Lundberg JO. Nitrite-derived nitric oxide: A possible mediator of ‘acidic-metabolic’ vasodilation. Acta Physiol Scand 2001; 171:9–16.
- Bai Y, Sun L, Yang T, Sun K, Chen J, Hui R. Increase in fasting vascular endothelial function after short-term oral l-arginine is effective when baseline flow-mediated dilation is low: A meta-analysis of randomized controlled trials. Am J Clin Nutr 2009; 89:77–84.
- Kosaka H. Nitric oxide and hemoglobin interactions in the vasculature. Biochim Biophys Acta 1999; 1411:370–377.
- Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am J Physiol 1996; 271:C1424–C1437.
- Roggensack AM, Zhang Y, Davidge ST. Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension 1999; 33:83–89.
- Seligman SP, Buyon JP, Clancy RM, Young BK, Abramson SB. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 1994; 171:944–948.
- Lass A, Suessenbacher A, Wolkart G, Mayer B, Brunner F. Functional and analytical evidence for scavenging of oxygen radicals by l-arginine. Mol Pharmacol 2002; 61:1081–1088.